Structural basis for the bypass of the major oxaliplatin–DNA adducts by human DNA polymerase η

Roles of Residues Arg-61 and Gln-38 of Human DNA Polymerase η in Bypass of Deoxyguanosine and 7,8-Dihydro-8-oxo-2′-deoxyguanosine

(2015) Yan Su et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Cisplatin in cancer therapy: Molecular mechanisms of action

(2014) Shaloam Dasari et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Structural basis for cisplatin DNA damage tolerance by human polymerase η during cancer chemotherapy

(2012) Ajay Ummat et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

Structural basis of human DNA polymerase  -mediated chemoresistance to cisplatin

(2012) Y. Zhao et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Overview of theCCP4 suite and current developments

(2011) Martyn D. Winn et al.   ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY

Molecular mechanisms of cisplatin resistance

(2011) L Galluzzi et al.   ONCOGENE

Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects

(2011) Ana-Maria Florea et al.   Cancers

The status of platinum anticancer drugs in the clinic and in clinical trials

(2010) Nial J. Wheate et al.   DALTON TRANSACTIONS

Requirement for functional DNA polymerase eta in genome-wide repair of UV-induced DNA damage during S phase

(2010) Yannick Auclair et al.   DNA REPAIR

Structure and mechanism of human DNA polymerase η

(2010) Christian Biertümpfel et al.   NATURE

Role of oxaliplatin in the treatment of colorectal cancer

(2010) Pasquale Comella   Therapeutics and Clinical Risk Management

Towards Antitumor Activetrans-Platinum Compounds

(2009) Sheena M. Aris et al.   EUROPEAN JOURNAL OF INORGANIC CHEMISTRY

Enhancing the efficacy of cisplatin in ovarian cancer treatment – could arsenic have a role

(2009) C William Helm et al.   Journal of Ovarian Research

DNA polymerases and human disease

(2008) Lawrence A. Loeb et al.   NATURE REVIEWS GENETICS